Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

S1 Ep8: The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

President and CEO

The Beat: Rethinking Valuations in Healthcare: The Next Horizon for V

Picture a venture capital industry leader with a distinct edge in healthcare, with over 40 years of focused practice and integration of partners with diverse expertise and networks. In this episode, <a href="https://www.linkedin.com/in/steve-kraus-5625901/overlay/about-this-profile/" target="_blank">Steve Kraus</a>, Bessemer Venture Partner, shares the Bessemer Venture Partners&#39; unique approach to investing, the current state of the VC industry, and the future of healthcare technology. Steve shares insights on how Bessemer leverages their deep expertise in healthcare and AI to attract the best founders and make impactful investments. He also addresses the recent challenges faced by the industry and offers an optimistic outlook on the upcoming valuation reset. Furthermore, Steve highlights the importance of outcomes-driven entrepreneurship and the potential for AI to revolutionize the healthcare sector.  Join us as we uncover the possibilities and opportunities in the evolving landscape of healthcare technology with Steve Krause. Stay tuned for a thought-provoking conversation ahead! About Steve Krause:Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He is the author of Bessemer’s <a href="https://www.bvp.com/atlas/roadmap-10-laws-of-healthcare/" target="_blank">10 Laws of Healthcare</a>, <a href="https://www.bvp.com/atlas/benchmarks-for-growing-health-tech-businesses/?from=spot" target="_blank">Benchmarks for Growing Health tech Businesses</a>, and is a co-host of <a href="https://www.bvp.com/atlas/a-healthy-dose/" target="_blank">A Healthy Dose</a> podcast. Steve currently sits on the boards of Bright Health Group, Headspace Health, Groups, Qventus, AspenRx, HouseRx, Oshi Health, Folx Health, Mural Health, Alcresta and US Health Partners. Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm and as a management consultant at Bain &amp; Company. He has also worked on several different political campaigns throughout his career. He serves as an Observer at Beth Israel Deaconess Medical Center, an advisor to Boston Children’s Hospital and the Harvard Business School’s Center for Entrepreneurship, and on the investment committees of BCBS Massachusetts and Rock Health. Steve graduated from summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar. <a href="https://www.bvp.com/team/steve-kraus" target="_blank">Source</a> Things You’ll Learn:<ul><li>With a dedicated healthcare practice for over 40 years, Bessemer brings a unique advantage by integrating partners with diverse industry expertise and networks. This approach allows them to make strategic investments in various industries, including healthcare, software as a service, fintech, consumer, and crypto.</li><li>The Intersection of Healthcare and AI: One of the fascinating topics discussed is how Bessemer leverages the convergence of healthcare and AI. </li><li>By combining Bessemer’s healthcare team&#39;s knowledge with a deep AI team, they have built one of the most extensive portfolios in healthcare AI today. This focus on innovation and emerging technologies positions them to tap into the potential of AI to drive down costs, improve outcomes, and revolutionize the healthcare industry.</li><li>Navigating the Current Landscape: With recent economic challenges, including market downturns and valuation adjustments, the VC industry has faced some headwinds. However, Steve Krause highlights that the current valuation reset has created opportunities for investors.</li><li>Steve emphasizes that the healthcare sector, in particular, holds immense potential, and as the public markets open up, the next cohort of healthcare tech companies will emerge, propelling the industry forward.</li></ul> Resources:<ul><li>Connect with and follow Steve Krause on <a href="https://www.linkedin.com/in/steve-kraus-5625901/" target="_blank">LinkedIn</a>.</li><li>Follow Bessemer on <a href="https://www.linkedin.com/company/bessemer-venture-partners/" target="_blank">LinkedIn</a> and visit their <a href="https://www.bvp.com/" target="_blank">website</a>.</li></ul>

S1 E2: The Beat: Rethinking Valuations in Healthcare: The Next Horizon for VC Investors

Leveraging Patient Voices to Inform Healthcare Policy—featuring Andy Slavitt

All too often, the people building healthcare solutions in the public sector have never seen a patient. The same goes for policymakers. And the voices of real people with real health problems get lost.  That’s why Andy Slavitt advocates for a collaborative approach to solving critical problems in healthcare. An approach that leverages the lived experiences of everyday Americans to inform innovation and policy. Andy is General Partner of <a href="https://www.townhallventures.com/" target="_blank">Town Hall Ventures</a>, a healthcare firm that invests in underrepresented communities, and Founder of <a href="https://unitedstatesofcare.org/" target="_blank">United States of Care</a>, a national nonprofit health advocacy organization. Andy has led many of the nation&#39;s most important healthcare initiatives, serving as President Obama&#39;s Head of Medicare and Medicaid and overseeing the turnaround, implementation, and defense of the Affordable Care Act. On this episode of HLTH Matters, Andy joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of public-private partnerships to drive innovation and policy decision making. Andy explains why policy drives innovation in healthcare, exploring the obstacles to adopting effective policy on a national level and what prevents hospital systems from prioritizing prevention over treatment.  Listen in for insight on what inspired Andy’s work with underserved communities and learn how he finds companies building simple healthcare solutions and invests in helping them scale. Topics Covered<ul><li>The experiences that inspired Andy’s work to serve underrepresented communities</li><li>Why it’s so challenging to build effective healthcare policy in our political system</li><li>Andy’s approach to solving critical problems in healthcare through collaboration among innovators, policymakers and everyday citizens</li><li>The common attributes of companies Andy invests in through Town Hall Ventures</li><li>Why Andy believes that policy drives innovation in the healthcare space</li><li>The obstacles to adopting effective healthcare policy on a national level</li><li>What prevents hospital systems from prioritizing prevention over treatment</li><li>How Andy invests in companies building simple healthcare solutions and helps them scale (e.g.: urgent care centers for mental health crises)</li></ul> Connect with Andy Slavitt<a href="https://www.townhallventures.com/" target="_blank">Town Hall Ventures</a><a href="https://unitedstatesofcare.org/" target="_blank">United States of Care</a><a href="https://podcasts.apple.com/us/podcast/in-the-bubble-with-andy-slavitt/id1504128553" target="_blank">In the Bubble Podcast</a>Andy on <a href="https://twitter.com/ASlavitt" target="_blank">X</a> Connect with Dr. Jessica Shepherd &amp; Dr. Gautam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a>Dr. Shepherd on <a href="https://twitter.com/JShepherd_MD" target="_blank">X</a>Dr. Shepherd on <a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">LinkedIn</a>Dr. Gulati on <a href="https://twitter.com/drgautamgulati" target="_blank">X</a>Dr. Gulati on <a href="https://www.linkedin.com/in/gautamgulati/" target="_blank">LinkedIn</a> Resources<a href="https://connectionshs.com/" target="_blank">Connections</a>

S4 E24: Leveraging Patient Voices to Inform Healthcare Policy—featuring Andy Slavitt

General Partner

Solving the Healthcare Equity Problem as a Whole—featuring Rajeev Singh

Let&#39;s stop talking about how hard healthcare is and improve the experience of its users. In this episode of the HLTH Matters Podcast, Rajeev Singh talks about how Accolade, the company he is CEO and chairman of, is working to provide a broad spectrum of solutions to tackle challenges healthcare has faced to make it more equitable. Accolade chose to be an umbrella solution for healthcare users, following their journeys and learning about their conditions and obstacles to improve their outcomes and their lives, and lower costs. Rajeev discusses health equity, diving into the structural and foundational challenges Accolade is tackling like affordability and access to virtual primary care and behavioral health specialists around the country. On top of the navigation factor, Accolade also thinks of adjacent factors that can impact the patients’ journeys like physician quality and cost. Tune in to learn how Accolade is working to make health equity a reality!  About Rajeev Singh:Rajeev Singh is the CEO and chairman of the Board of Directors at Accolade (Nasdaq: ACCD). He joined Accolade as CEO in November of 2015, leading the organization’s strategy and operations through high growth.   In 2020, Singh led Accolade through one of the first digital healthcare Initial Public Offerings of the year. The following year, he led the company through nearly $1 billion in acquisitions of 2nd.MD, PlushCare, and HealthReveal. Accolade now works with over 700 employers and health plans serving over 11 million people across the United States.   Prior to joining Accolade, he co-founded Concur, the global leader in travel and expense management, in 1993. Concur went public (Nasdaq: CNQR) in 1998 and grew to more than $800mm in revenue, over 4,000 employees, and more than 25,000 customers before being acquired by SAP AG for $8.3 billion in 2014. Singh was president and chief operating officer as well as a member of the board of directors at Concur.   Singh graduated from Western Michigan University with a BSE. Today, he serves on the board of Avalara (NYSE: AVLR), a top provider of cloud-based tax compliance automation for businesses; Amperity, an intelligent customer data platform; Seattle Children’s Hospital Foundation; and the University of Washington Foundation. He lives in Seattle with his wife, Jill, and their 2 children.  Things You’ll Learn:<ul><li>Accolade defines health equity as the responsibility to ensure everyone has the inalienable human right to high-quality healthcare. </li><li>If you live in specific neighborhoods in the United States or are part of a particular minority group, you might not have access to a primary care physician. </li><li>The LGBTQ+ population struggles to find the primary care and behavioral health they need within a shared life experience.</li><li>The biggest financial challenge most people face in their lives is affording healthcare.</li><li>2020 made access to virtual care mainstream in the United States, creating an opportunity that has to be embraced. </li></ul> Resources:<ul><li>Connect with and follow Rajeev Singh on <a href="https://www.linkedin.com/in/rajeevsinghseattle/" target="_blank">LinkedIn</a>.</li><li>Follow Accolade on <a href="https://www.linkedin.com/company/accolade-inc-/" target="_blank">LinkedIn</a>.</li><li>Explore the Accolade <a href="https://www.accolade.com/" target="_blank">Website</a>!</li><li>Reach out to Rajeev at <a href="" target="_blank">RajeevSingh@Accolade.com</a>. </li></ul>

S3 Ep52: Solving the Healthcare Equity Problem as a Whole—featuring Rajeev Singh

Podcast

S1 Ep8: The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

FEATURING